Brief: Alligator Bioscience Q4 EBIT SEK -22.5 Million
12/02/2026 07:00
Feb 12 (Reuters) - Alligator Bioscience Q4 adjusted EPS SEK -0.66. Q4 net income SEK -29 million
Recent news on Alligator Bioscience AB
See all newsSweden's Alligator Bioscience Q3 sales fall as R&D winds down
Brief: Alligator Bioscience Q3 EBIT SEK -19.3 Million
Brief: Alligator Bioscience Appoints Johan Gileus As CEO
Brief: Alligator Bioscience Announces Final Outcome In Rights Issue
Brief: Alligator Bioscience To Initially Receive SEK 58.8 Mln From Rights Issue